HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-OCT-10 3P9J TITLE AURORA A KINASE DOMAIN WITH PHTHALAZINONE PYRAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 124-391; COMPND 5 SYNONYM: AURORA KINASE A, AURORA/IPL1-RELATED KINASE 1, ARK-1, COMPND 6 AURORA-RELATED KINASE 1, HARK1, BREAST TUMOR-AMPLIFIED KINASE, COMPND 7 SERINE/THREONINE-PROTEIN KINASE 15, SERINE/THREONINE-PROTEIN KINASE COMPND 8 AURORA-A; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AIK, ARK1, AURA, AURKA, BTAK, STK15, STK6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHOTRANSFERASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.A.KAIRIES,T.OLIVEIRA,R.A.ENGH REVDAT 4 21-FEB-24 3P9J 1 REMARK SEQADV REVDAT 3 17-JUL-19 3P9J 1 REMARK REVDAT 2 05-OCT-11 3P9J 1 JRNL VERSN REVDAT 1 23-MAR-11 3P9J 0 JRNL AUTH M.E.PRIME,S.M.COURTNEY,F.A.BROOKFIELD,R.W.MARSTON,V.WALKER, JRNL AUTH 2 J.WARNE,A.E.BOYD,N.A.KAIRIES,W.VON DER SAAL,A.LIMBERG, JRNL AUTH 3 G.GEORGES,R.A.ENGH,B.GOLLER,P.RUEGER,M.RUETH JRNL TITL PHTHALAZINONE PYRAZOLES AS POTENT, SELECTIVE, AND ORALLY JRNL TITL 2 BIOAVAILABLE INHIBITORS OF AURORA-A KINASE. JRNL REF J.MED.CHEM. V. 54 312 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21128645 JRNL DOI 10.1021/JM101346R REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7_650 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.76 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.920 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 9048 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.640 REMARK 3 FREE R VALUE TEST SET COUNT : 420 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.36 REMARK 3 B_SOL : 41.59 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.430 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.29890 REMARK 3 B22 (A**2) : -0.29890 REMARK 3 B33 (A**2) : 0.59770 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2117 REMARK 3 ANGLE : 1.223 2861 REMARK 3 CHIRALITY : 0.091 304 REMARK 3 PLANARITY : 0.005 363 REMARK 3 DIHEDRAL : 16.405 789 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3P9J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062126. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9050 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 24.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3350, PH 7, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.39700 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 112.79400 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 84.59550 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 140.99250 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.19850 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.39700 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 112.79400 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 140.99250 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 84.59550 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.19850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 16 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 124 REMARK 465 LYS A 125 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 ARG A 285 REMARK 465 ARG A 286 REMARK 465 ALA A 287 REMARK 465 ALA A 288 REMARK 465 LEU A 289 REMARK 465 CYS A 290 REMARK 465 ARG A 304 REMARK 465 MET A 305 REMARK 465 HIS A 306 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 307 N CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CD2 HIS A 201 CG2 VAL A 206 1.68 REMARK 500 NE2 HIS A 201 CG2 VAL A 206 1.84 REMARK 500 NE2 HIS A 201 CG1 VAL A 206 1.97 REMARK 500 OE2 GLU A 134 NH2 ARG A 151 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 143 -46.01 65.11 REMARK 500 ASP A 202 -169.60 -125.61 REMARK 500 SER A 226 -32.27 72.14 REMARK 500 LEU A 293 19.20 -140.20 REMARK 500 GLU A 308 -16.17 82.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 141 GLY A 142 137.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P9J A 1 DBREF 3P9J A 125 391 UNP O14965 STK6_HUMAN 125 391 SEQADV 3P9J ALA A 124 UNP O14965 EXPRESSION TAG SEQADV 3P9J ALA A 287 UNP O14965 THR 287 ENGINEERED MUTATION SEQADV 3P9J ALA A 288 UNP O14965 THR 288 ENGINEERED MUTATION SEQRES 1 A 268 ALA LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 A 268 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 A 268 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 A 268 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 A 268 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 A 268 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 A 268 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 A 268 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 A 268 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 A 268 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 A 268 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 A 268 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 A 268 HIS ALA PRO SER SER ARG ARG ALA ALA LEU CYS GLY THR SEQRES 14 A 268 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 A 268 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 A 268 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 A 268 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 A 268 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 A 268 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 A 268 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 A 268 THR ALA ASN SER SER LYS PRO SER HET P9J A 1 24 HETNAM P9J 4-[(5-METHYL-1H-PYRAZOL-3-YL)AMINO]-2-PHENYLPHTHALAZIN- HETNAM 2 P9J 1(2H)-ONE FORMUL 2 P9J C18 H15 N5 O FORMUL 3 HOH *19(H2 O) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 LYS A 171 1 6 HELIX 3 3 VAL A 174 SER A 186 1 13 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 PRO A 297 GLY A 303 1 7 HELIX 8 8 LYS A 309 GLY A 325 1 17 HELIX 9 9 THR A 333 VAL A 344 1 12 HELIX 10 10 THR A 353 LEU A 364 1 12 HELIX 11 11 ASN A 367 ARG A 371 5 5 HELIX 12 12 MET A 373 HIS A 380 1 8 HELIX 13 13 HIS A 380 SER A 387 1 8 SHEET 1 A 5 PHE A 133 GLY A 142 0 SHEET 2 A 5 GLY A 145 GLU A 152 -1 O LEU A 149 N GLY A 136 SHEET 3 A 5 ILE A 158 PHE A 165 -1 O LEU A 159 N ALA A 150 SHEET 4 A 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 A 5 LEU A 196 HIS A 201 -1 N PHE A 200 O TYR A 207 SHEET 1 B 2 ILE A 253 HIS A 254 0 SHEET 2 B 2 TRP A 277 SER A 278 -1 O SER A 278 N ILE A 253 SHEET 1 C 2 LEU A 262 LEU A 264 0 SHEET 2 C 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 CISPEP 1 THR A 292 LEU A 293 0 -0.02 SITE 1 AC1 8 LEU A 139 ALA A 160 GLU A 211 TYR A 212 SITE 2 AC1 8 ALA A 213 PRO A 214 GLY A 216 LEU A 263 CRYST1 83.113 83.113 169.191 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012032 0.006947 0.000000 0.00000 SCALE2 0.000000 0.013893 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005910 0.00000